{
    "2020-10-27": [
        [
            {
                "time": "",
                "original_text": "智飞生物(300122.SZ)：股东吴冠江减持期届满累计减持2956.85万股 减持股份",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "股东减持",
                        "吴冠江",
                        "减持计划"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：吴冠江累计减持1.85%股份，减持计划届满 拟减持股份",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "吴冠江",
                        "减持计划",
                        "累计减持"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：板块整体回调 季报期关注业绩确定性",
                "features": {
                    "keywords": [
                        "医药生物",
                        "板块回调",
                        "季报期",
                        "业绩确定性"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "晨会纪要2020年第187期",
                "features": {
                    "keywords": [
                        "晨会纪要",
                        "2020年",
                        "第187期"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "生物医药行业深度报告：疫情、医保、集采 影响终端销售的三个关键词",
                "features": {
                    "keywords": [
                        "生物医药",
                        "疫情",
                        "医保",
                        "集采",
                        "终端销售"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}